5,353 findings · Hormonal · published 2017+
- HormonalGood
Higher levels of objectively measured physical activity are causally associated with a significantly lower risk of developing breast and colorectal cancers.
To lower your risk of breast and colorectal cancer, focus on increasing your daily movement rather than intense, time-consuming workouts. The research indicates that a modest increase in average daily acceleration—equivalent to adding about 50 minutes of moderate activity (like brisk walking) or 8 minutes of vigorous activity (like running) per week—is causally linked to significantly lower cancer risks. This benefit appears to be independent of weight loss, suggesting that the act of moving itself triggers protective biological mechanisms.
Supports 2020 - HormonalGood
Chronic elevation of the myokine IL-6 in obesity contributes to insulin resistance, contrasting with its acute anti-inflammatory and insulin-sensitizing effects during exercise.
Don't fear all inflammation. Acute spikes in IL-6 from exercise improve insulin sensitivity. However, chronic high levels of IL-6 associated with obesity contribute to insulin resistance. Focus on reducing chronic inflammation through weight management.
Qualifies 2017 - HormonalGood
Exercise improves mental health and cognitive function through mechanisms involving BDNF, IGF-1, and myokines like FNDC5 and PGC-1α, which promote neurogenesis and synaptic plasticity.
Regular exercise boosts brain-derived neurotrophic factor (BDNF) and other growth factors that support brain health and reduce the risk of depression. Make exercise a regular part of your routine to support your mental well-being.
Supports 2017 - HormonalGood
Exercise improves glucose tolerance and insulin sensitivity through mechanisms independent of the insulin receptor, bypassing insulin resistance in type 2 diabetes.
If you have type 2 diabetes or are at risk, exercise helps your muscles take up glucose without relying on insulin. This bypasses the resistance that makes medication less effective. Combine exercise with other lifestyle changes for the best results.
Supports 2017 - HormonalGood
High levels of sedentary behavior independently increase the risk of colon, endometrial, and lung cancers, regardless of physical activity levels.
Reduce uninterrupted sitting time. Stand up, walk, or stretch periodically throughout the day. This reduces cancer risk independently of your exercise routine.
Supports 2020 - HormonalGood
Gut microbiota composition and metabolite production (specifically short-chain fatty acids and lipopolysaccharides) trigger chronic low-grade metabolic inflammation (metainflammation), which directly causes insulin resistance and contributes to the development of Type 2 Diabetes.
Focus on dietary patterns that support a diverse gut microbiome, such as high-fiber foods, to potentially reduce systemic inflammation and improve insulin sensitivity. While not a standalone cure, managing gut health is a critical lever in preventing or managing Type 2 Diabetes alongside traditional lifestyle changes.
Supports 2020 - HormonalGood
Blueberry consumption improves cardiovascular biomarkers, including blood pressure, arterial stiffness, and lipid profiles, particularly in individuals with hypertension or metabolic syndrome.
If you have high blood pressure or metabolic syndrome, adding blueberries to your diet may help lower your blood pressure and improve arterial stiffness. This is not a replacement for medication but a supportive dietary strategy.
Supports 2019 - HormonalGood
Exposure to bright light (7,000–10,000 lux) for 30–60 minutes daily, particularly in the early morning, is an effective, non-invasive intervention for treating Seasonal Affective Disorder (SAD) and non-seasonal depression.
Use a medical-grade light therapy lamp delivering 7,000–10,000 lux. Sit about 20-35 cm away for 30-60 minutes every morning. You do not need to stare directly at the light; just keep your eyes open and you can read or work. If you have eye conditions like retinal detachment or take photosensitizing drugs, consult a doctor first. Consistency is key: daily use yields the best results.
Supports 2019 - HormonalGood
Evening exposure to artificial light, particularly from LED screens and smartphones, delays circadian phase, suppresses melatonin, and reduces sleep quality and duration.
Avoid bright screens (phones, tablets, LEDs) for at least 2-4 hours before bedtime. If you must use them, dim the brightness to the lowest possible level and use 'night mode' to reduce blue light. Be aware that psychological engagement from content may also disrupt sleep, so consider winding down with non-screen activities.
Supports 2019 - HormonalGood
GLP-1 receptor agonists (specifically Liraglutide 3.0 mg/day) induce significant weight loss (median 63% achieving ≥5% loss) and reduce hepatic steatosis, potentially through mechanisms independent of weight loss.
If lifestyle changes are insufficient, GLP-1 receptor agonists like Liraglutide (3.0 mg/day) are highly effective. They help patients lose significant weight (average 8%) and directly reduce liver fat and inflammation. This is particularly relevant for patients with Type 2 Diabetes.
Supports 2020 - HormonalGood
Adipose tissue distribution, specifically lower intra-abdominal adipose tissue (IAAT) and lower intrahepatic triglyceride content, distinguishes metabolically healthy obesity from metabolically unhealthy obesity, rather than total body fat percentage.
Focus on reducing visceral and liver fat rather than just total weight. This can be achieved through aerobic exercise and dietary changes that improve insulin sensitivity, even if total body fat percentage remains similar.
Supports 2019 - HormonalGood
Non-alcoholic fatty liver disease (NAFLD) is independently associated with a significantly increased risk of cardiovascular disease (CVD) morbidity and mortality, particularly in patients with advanced fibrosis or non-alcoholic steatohepatitis (NASH).
If you have NAFLD, you must prioritize cardiovascular health. Regular screening for blood pressure, cholesterol, and blood sugar is essential, even if your liver feels fine. The presence of fatty liver is a strong warning sign for heart disease, so aggressive management of metabolic risk factors is required to reduce mortality.
Supports 2020 - HormonalGood
NAFLD is associated with an increased risk of cardiac arrhythmias, specifically atrial fibrillation and ventricular arrhythmias, independent of traditional cardiovascular risk factors.
If you have NAFLD, be aware of symptoms like palpitations or irregular heartbeat. Screening for arrhythmias like atrial fibrillation is recommended, especially if you also have diabetes, as the risk is significantly elevated.
Supports 2020 - HormonalGood
Irregular sleep/wake patterns are associated with delayed circadian timing (later melatonin onset) and lower academic performance in college students, primarily driven by irregular light exposure patterns rather than intrinsic circadian physiology.
Maintain a consistent sleep schedule, even on weekends. Irregular sleep delays your internal body clock (melatonin onset) and is linked to lower grades, independent of how many hours you sleep. Use light exposure strategically: get bright light in the morning and limit bright light at night to stabilize your rhythm.
Supports 2017 - HormonalGood
Post-activation potentiation (PAP) is a distinct physiological phenomenon from post-activation performance enhancement (PAPE), characterized by a short half-life (~28s) driven by myosin light chain phosphorylation, whereas PAPE occurs 6-10 minutes post-activity and is likely driven by increased muscle temperature and activation rather than PAP mechanisms.
Do not assume that a heavy warm-up improves your subsequent performance solely through 'post-activation potentiation.' The paper suggests that PAP (a biochemical state) fades quickly (~30s), while voluntary performance gains (PAPE) peak later (6-10 minutes) and are likely driven by increased muscle temperature and neural activation. Design your warm-up to allow time for these physiological changes to occur, and recognize that 'potentiation' is not the sole or primary driver of late-phase performance boosts.
Qualifies 2019 - HormonalGood
Untreated thyroid dysfunction (both hyper- and hypothyroidism) impairs metabolic control in diabetic patients, exacerbating glycemic instability and increasing the risk of microvascular complications.
If you have diabetes, your thyroid health directly impacts your blood sugar control. Untreated thyroid issues (even subclinical ones) can make your diabetes harder to manage. You should be screened for thyroid dysfunction (TSH, TPO antibodies) regularly, and if found, treating the thyroid issue is essential to achieving stable glucose levels.
Supports 2019 - HormonalGood
Subclinical hypothyroidism (SHypo) is more prevalent in patients with Type 2 Diabetes (T2D) than in the general population and is associated with an increased risk of diabetic microvascular complications.
If you have Type 2 Diabetes, you are nearly twice as likely to have subclinical hypothyroidism compared to someone without diabetes. This condition is linked to a higher risk of eye, kidney, and nerve complications. Regular thyroid screening is part of comprehensive diabetes care.
Supports 2019 - HormonalGood
Delaying meal timing by 5 hours in healthy young men significantly delays the phase of plasma glucose circadian rhythms and reduces mean plasma glucose concentration, while delaying white adipose tissue (WAT) PER2 clock gene expression, without affecting the central master clock (melatonin/cortisol) or insulin/triglyceride rhythms.
If you work shifts or have jet lag, try shifting your main meals later to align with your new schedule. This won't change your sleep hormone (melatonin) timing, but it will help synchronize your body's peripheral clocks (like those in your fat tissue) and improve how your body handles glucose throughout the day. Keep meals isocaloric and consistent in composition.
Supports 2017 - HormonalGood
Women with type 2 diabetes face a significantly higher relative risk of cardiovascular disease and mortality compared to men, despite often being diagnosed at a lower body mass index and younger age.
If you are a woman with type 2 diabetes, your risk of heart disease and death is higher relative to a man with diabetes, even if your weight is lower. This risk is amplified by hormonal changes like menopause and pregnancy history. You need aggressive management of blood pressure, lipids, and glucose, potentially starting earlier than guidelines might suggest for men, because your body may have more advanced heart vessel damage at the time of diagnosis.
Supports 2023 - HormonalGood
Endurance training can induce muscle hypertrophy (7-11% increase in mass) in the quadriceps, particularly in sedentary individuals or those with limited exercise experience, through mechanisms independent of mTORC1.
If you are new to exercise or sedentary, starting an endurance program like cycling will likely build muscle in your legs, not just burn calories. This hypertrophy is comparable to what you might see from resistance training over the same period.
Supports 2017 - HormonalGood
Insulin resistance (IR) is a central pathophysiological mechanism that drives the development and progression of multiple metabolic diseases, including type 2 diabetes, cardiovascular disease, nonalcoholic fatty liver disease (NAFLD), and certain cancers.
Insulin resistance is not just a blood sugar issue; it is a systemic driver of chronic disease. Addressing it through lifestyle changes (exercise, diet) or medications (like metformin or GLP-1 agonists) can potentially improve multiple health outcomes at once, including heart health, liver health, and diabetes management. Prioritizing insulin sensitivity is a high-leverage strategy for overall metabolic health.
Supports 2023 - HormonalGood
Obesity, particularly central/visceral obesity, is a primary cause of insulin resistance through mechanisms involving increased free fatty acids, chronic inflammation, and adipokine dysregulation.
Losing even a modest amount of weight (e.g., 10% of body weight) can significantly improve insulin sensitivity, especially if the weight is visceral fat. Focus on reducing abdominal fat through caloric deficit and exercise, as this directly addresses the root cause of obesity-induced insulin resistance.
Supports 2023 - HormonalGood
Chronic low-grade inflammation, driven by obesity and characterized by elevated pro-inflammatory cytokines (TNF-alpha, IL-6, CRP), directly interferes with insulin signaling pathways, contributing to insulin resistance.
Chronic low-grade inflammation, common in obesity, disrupts insulin signaling. Anti-inflammatory lifestyle strategies (e.g., Mediterranean diet, regular exercise, stress management) can help reduce this inflammation and improve insulin sensitivity.
Supports 2023 - HormonalGood
Food intake stimulates insulin release and mTOR-dependent protein synthesis in muscle, while excess amino acids are oxidized leading to increased urea production.
After eating, your body uses amino acids to build muscle (via mTOR and insulin) and oxidizes any excess for energy, producing urea. This highlights that protein has a limit to how much can be used for synthesis at once.
Supports 2017